Aurora Pharmaceutical, however, is taking a different approach. Aurora Pharmaceutical logo Under the leadership of CEO Dr. Mike Strobel - a career veterinarian who grew up on a cattle farm - the ...

Brad Setser’s testimony to the United States Senate Committee on Finance addresses pharmaceutical manufacturers and U.S. international tax policy. I want to thank Chairman Wyden, Ranking Member ...

Pharmaceutical manufacturing sits at the intersection of science, technology, and global health—driving critical advances in how medicines are developed, produced, and delivered. News Medical ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

BERLIN, April 25, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

Susquehanna analyst Charles Minervino maintained a Buy rating on Patterson-UTI (PTEN – Research Report) yesterday and set a price target of $9.00. The company’s shares closed yesterday at $6.10.

At the beginning of the month, the new service provider, UTi Pharma, informed the department of Health of backlogs in the dispensing and production processes at their new facility, resulting in the ...

The AA was hearing the Show Cause Notice (SCN) contested by Mahindra and Mahindra Ltd (M&M) seeking a demand of Rs. 146 crores by the GST for use of its brand name by its subsidiaries . While the AA ...

Indian pharmaceutical giant Zydus Lifesciences has a lost patent battle with Tokyo-based Astellas Pharma. The US District Court for Delaware upheld the validity of a patent concerning Myrbetriq, a ...

The pharmaceutical industry has a crucial role in modern healthcare, but it also has a significant environmental footprint. From large-scale solvent use and carbon emissions to water pollution and ...

RBC Capital lowered the firm’s price target on Patterson-UTI (PTEN) to $9.50 from $11 and keeps an Outperform rating on the shares as part of a broader research note on Oil & Gas Equipment ...